Key facts
- This page summarizes Atai Beckley N.V.'s Form 4 filing for COMPASS Pathways plc (CMPS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Sep 2024, 20:00.
Atai Beckley N.V. - 26 Sep 2024 Form 4 Insider Report for COMPASS Pathways plc (CMPS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CMPS
- Reported as of
- 26 Sep 2024
- Net transaction value
- -$16,093,000
- SEC form
- 4
- Accepted by SEC
- 27 Sep 2024, 20:00:43 UTC
- Prior SEC filing
- 03 May 2024
- Source filing
- View source filing
- Reporting owner signature
- ATAI Life Sciences N.V., By: /s/ Anne Johnson, Chief Financial Officer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Atai Beckley N.V. filed Form 4 for COMPASS Pathways plc (CMPS) on 27 Sep 2024.
Change
- Previous filing in this sequence was filed on 03 May 2024.
- Current net transaction value: -$16,093,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMPS
transaction
Ordinary Shares
Sale
- Transaction value
- $16,093,000
- Shares
- -2,660,000
- Change %
- -28%
- Price
- $6.05
- Shares after
- 6,905,774
- Date
- 26 Sep 2024
- Ownership
- By ATAI Life Sciences AG
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Securities held of record by ATAI Life Sciences AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the Ordinary Shares held of record by ATAI Life Sciences AG.